Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
Jo Steinson StenehjemKnut B SmelandKlaus MurbraechHarald HolteStein Olav KvaløyTorgeir WethalCecilie E KiserudMay Brit Samersaw-LundPublished in: Acta oncologica (Stockholm, Sweden) (2017)
Despite intensive cancer treatment, our analysis showed modest reductions in obstructive parameters among long-term LSs after HDT-ASCT compared to normative reference data. To limit obstructive impairments in LSs after HDT-ASCT, we suggest that targeted smoking-cessation advice is directed towards patients who have received high cumulative doses of doxorubicin.
Keyphrases
- high dose
- stem cell transplantation
- smoking cessation
- end stage renal disease
- low dose
- ejection fraction
- replacement therapy
- chronic kidney disease
- cancer therapy
- prognostic factors
- pulmonary hypertension
- bone marrow
- young adults
- diffuse large b cell lymphoma
- cell therapy
- patient reported outcomes
- electronic health record